First Manhattan CO Anixa Biosciences Inc Transaction History

First Manhattan CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$3.27 - $7.14 $21,255 - $46,410	6,500 New	6,500 $30,000
Q4 2019 Feb 13, 2020	SELL	$2.78 - $4.03 $556 - $806	-200 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$3.37 - $6.59 $674 - $1,318	200 New	200 $0

5.73M

7.1K

26.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $96.9M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.